The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?

Extended overuse and misuse of antibiotics and other antibacterial agents has resulted in an antimicrobial resistance crisis. Bacteriophages, viruses that infect bacteria, have emerged as a legitimate alternative antibacterial agent with a wide scope of applications which continue to be discovered a...

Full description

Bibliographic Details
Main Authors: Ahmad Y. Hassan, Janet T. Lin, Nicole Ricker, Hany Anany
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/14/3/199
_version_ 1797417189474566144
author Ahmad Y. Hassan
Janet T. Lin
Nicole Ricker
Hany Anany
author_facet Ahmad Y. Hassan
Janet T. Lin
Nicole Ricker
Hany Anany
author_sort Ahmad Y. Hassan
collection DOAJ
description Extended overuse and misuse of antibiotics and other antibacterial agents has resulted in an antimicrobial resistance crisis. Bacteriophages, viruses that infect bacteria, have emerged as a legitimate alternative antibacterial agent with a wide scope of applications which continue to be discovered and refined. However, the potential of some bacteriophages to aid in the acquisition, maintenance, and dissemination of negatively associated bacterial genes, including resistance and virulence genes, through transduction is of concern and requires deeper understanding in order to be properly addressed. In particular, their ability to interact with mobile genetic elements such as plasmids, genomic islands, and integrative conjugative elements (ICEs) enables bacteriophages to contribute greatly to bacterial evolution. Nonetheless, bacteriophages have the potential to be used as therapeutic and biocontrol agents within medical, agricultural, and food processing settings, against bacteria in both planktonic and biofilm environments. Additionally, bacteriophages have been deployed in developing rapid, sensitive, and specific biosensors for various bacterial targets. Intriguingly, their bioengineering capabilities show great promise in improving their adaptability and effectiveness as biocontrol and detection tools. This review aims to provide a balanced perspective on bacteriophages by outlining advantages, challenges, and future steps needed in order to boost their therapeutic and biocontrol potential, while also providing insight on their potential role in contributing to bacterial evolution and survival.
first_indexed 2024-03-09T06:15:14Z
format Article
id doaj.art-f356336279994319909ee9197a77820b
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-09T06:15:14Z
publishDate 2021-02-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-f356336279994319909ee9197a77820b2023-12-03T11:54:25ZengMDPI AGPharmaceuticals1424-82472021-02-0114319910.3390/ph14030199The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?Ahmad Y. Hassan0Janet T. Lin1Nicole Ricker2Hany Anany3Guelph Research and Development Centre, Agriculture and Agri-Food Canada, Guelph, ON N1G 5C9, CanadaDepartment of Molecular and Cellular Biology, College of Biological Science, University of Guelph, Guelph, ON N1G 2W1, CanadaDepartment of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, CanadaGuelph Research and Development Centre, Agriculture and Agri-Food Canada, Guelph, ON N1G 5C9, CanadaExtended overuse and misuse of antibiotics and other antibacterial agents has resulted in an antimicrobial resistance crisis. Bacteriophages, viruses that infect bacteria, have emerged as a legitimate alternative antibacterial agent with a wide scope of applications which continue to be discovered and refined. However, the potential of some bacteriophages to aid in the acquisition, maintenance, and dissemination of negatively associated bacterial genes, including resistance and virulence genes, through transduction is of concern and requires deeper understanding in order to be properly addressed. In particular, their ability to interact with mobile genetic elements such as plasmids, genomic islands, and integrative conjugative elements (ICEs) enables bacteriophages to contribute greatly to bacterial evolution. Nonetheless, bacteriophages have the potential to be used as therapeutic and biocontrol agents within medical, agricultural, and food processing settings, against bacteria in both planktonic and biofilm environments. Additionally, bacteriophages have been deployed in developing rapid, sensitive, and specific biosensors for various bacterial targets. Intriguingly, their bioengineering capabilities show great promise in improving their adaptability and effectiveness as biocontrol and detection tools. This review aims to provide a balanced perspective on bacteriophages by outlining advantages, challenges, and future steps needed in order to boost their therapeutic and biocontrol potential, while also providing insight on their potential role in contributing to bacterial evolution and survival.https://www.mdpi.com/1424-8247/14/3/199bacteriophagephage therapybiocontroltransductionantibiotic resistance
spellingShingle Ahmad Y. Hassan
Janet T. Lin
Nicole Ricker
Hany Anany
The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?
Pharmaceuticals
bacteriophage
phage therapy
biocontrol
transduction
antibiotic resistance
title The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?
title_full The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?
title_fullStr The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?
title_full_unstemmed The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?
title_short The Age of Phage: Friend or Foe in the New Dawn of Therapeutic and Biocontrol Applications?
title_sort age of phage friend or foe in the new dawn of therapeutic and biocontrol applications
topic bacteriophage
phage therapy
biocontrol
transduction
antibiotic resistance
url https://www.mdpi.com/1424-8247/14/3/199
work_keys_str_mv AT ahmadyhassan theageofphagefriendorfoeinthenewdawnoftherapeuticandbiocontrolapplications
AT janettlin theageofphagefriendorfoeinthenewdawnoftherapeuticandbiocontrolapplications
AT nicolericker theageofphagefriendorfoeinthenewdawnoftherapeuticandbiocontrolapplications
AT hanyanany theageofphagefriendorfoeinthenewdawnoftherapeuticandbiocontrolapplications
AT ahmadyhassan ageofphagefriendorfoeinthenewdawnoftherapeuticandbiocontrolapplications
AT janettlin ageofphagefriendorfoeinthenewdawnoftherapeuticandbiocontrolapplications
AT nicolericker ageofphagefriendorfoeinthenewdawnoftherapeuticandbiocontrolapplications
AT hanyanany ageofphagefriendorfoeinthenewdawnoftherapeuticandbiocontrolapplications